Stem Cell Therapy for Vascular Regeneration: Adult, Embryonic, and Induced Pluripotent Stem Cells

Overview

Journal Circulation

Specialty Cardiology & Vascular Diseases

Date 2010 Aug 4

PMID 20679581

Citations 104

Authors

Nicholas J Leeper

Arwen L Hunter

John P Cooke

Affiliations

Soon will be listed here.

Citing Articles

Revolutionizing medicine: recent developments and future prospects in stem-cell therapy.

Hussen B, Hussen B, Taheri M, Yashooa R, Abdullah G, Abdullah S Int J Surg. 2024; 110(12):8002-8024.

PMID: 39497543 PMC: 11634165. DOI: 10.1097/JS9.0000000000002109.

A simple guideline for designing droplet microfluidic chips to achieve an improved single (bio)particle encapsulation rate using a stratified flow-assisted particle ordering method.

Nguyen T, Ezzo N, Chan S, Yim E, Ren C Biomicrofluidics. 2024; 18(5):054110.

PMID: 39397893 PMC: 11466506. DOI: 10.1063/5.0219528.

Characterization and angiogenic potential of CD146 endometrial stem cells.

Hilage P, Birajdar A, Marsale T, Patil D, Patil A, Telang G Stem Cell Res Ther. 2024; 15(1):330.

PMID: 39334237 PMC: 11438155. DOI: 10.1186/s13287-024-03918-7.

Application of Pro-angiogenic Biomaterials in Myocardial Infarction.

Liang T, Liu J, Liu F, Su X, Li X, Zeng J ACS Omega. 2024; 9(36):37505-37529.

PMID: 39281944 PMC: 11391569. DOI: 10.1021/acsomega.4c04682.

Enhancing endothelial colony-forming cells for treating diabetic vascular complications: challenges and clinical prospects.

Liu Y, Lyons C, Ayu C, OBrien T Front Endocrinol (Lausanne). 2024; 15:1396794.

PMID: 39076517 PMC: 11284052. DOI: 10.3389/fendo.2024.1396794.

References

Arai M, Misao Y, Nagai H, Kawasaki M, Nagashima K, Suzuki K . Granulocyte colony-stimulating factor: a noninvasive regeneration therapy for treating atherosclerotic peripheral artery disease. Circ J. 2006; 70(9):1093-8. DOI: 10.1253/circj.70.1093. View

Blum B, Benvenisty N . The tumorigenicity of human embryonic stem cells. Adv Cancer Res. 2008; 100:133-58. DOI: 10.1016/S0065-230X(08)00005-5. View

Higashi Y, Kimura M, Hara K, Noma K, Jitsuiki D, Nakagawa K . Autologous bone-marrow mononuclear cell implantation improves endothelium-dependent vasodilation in patients with limb ischemia. Circulation. 2004; 109(10):1215-8. DOI: 10.1161/01.CIR.0000121427.53291.78. View

Loffredo F, Lee R . Therapeutic vasculogenesis: it takes two. Circ Res. 2008; 103(2):128-30. PMC: 2720099. DOI: 10.1161/CIRCRESAHA.108.180604. View

Woltjen K, Michael I, Mohseni P, Desai R, Mileikovsky M, Hamalainen R . piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells. Nature. 2009; 458(7239):766-70. PMC: 3758996. DOI: 10.1038/nature07863. View

Okita K, Ichisaka T, Yamanaka S . Generation of germline-competent induced pluripotent stem cells. Nature. 2007; 448(7151):313-7. DOI: 10.1038/nature05934. View

Narazaki G, Uosaki H, Teranishi M, Okita K, Kim B, Matsuoka S . Directed and systematic differentiation of cardiovascular cells from mouse induced pluripotent stem cells. Circulation. 2008; 118(5):498-506. DOI: 10.1161/CIRCULATIONAHA.108.769562. View

Tse H, Thambar S, Kwong Y, Rowlings P, Bellamy G, McCrohon J . Prospective randomized trial of direct endomyocardial implantation of bone marrow cells for treatment of severe coronary artery diseases (PROTECT-CAD trial). Eur Heart J. 2007; 28(24):2998-3005. DOI: 10.1093/eurheartj/ehm485. View

Wernig M, Meissner A, Cassady J, Jaenisch R . c-Myc is dispensable for direct reprogramming of mouse fibroblasts. Cell Stem Cell. 2008; 2(1):10-2. DOI: 10.1016/j.stem.2007.12.001. View

10.

Xie C, Huang H, Wei S, Song L, Zhang J, Ritchie R . A comparison of murine smooth muscle cells generated from embryonic versus induced pluripotent stem cells. Stem Cells Dev. 2008; 18(5):741-8. PMC: 2914231. DOI: 10.1089/scd.2008.0179. View

11.

Kondo K, Shintani S, Shibata R, Murakami H, Murakami R, Imaizumi M . Implantation of adipose-derived regenerative cells enhances ischemia-induced angiogenesis. Arterioscler Thromb Vasc Biol. 2008; 29(1):61-6. DOI: 10.1161/ATVBAHA.108.166496. View

12.

Brixius K, Funcke F, Graf C, Bloch W . Endothelial progenitor cells: a new target for the prevention of cardiovascular diseases. Eur J Cardiovasc Prev Rehabil. 2006; 13(5):705-10. DOI: 10.1097/01.hjr.0000221862.34662.31. View

13.

Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T . Isolation of putative progenitor endothelial cells for angiogenesis. Science. 1997; 275(5302):964-7. DOI: 10.1126/science.275.5302.964. View

14.

Yamanaka S . Pluripotency and nuclear reprogramming. Philos Trans R Soc Lond B Biol Sci. 2008; 363(1500):2079-87. PMC: 2610180. DOI: 10.1098/rstb.2008.2261. View

15.

Young H, Duplaa C, Katz R, Thompson T, Hawkins K, Boev A . Adult-derived stem cells and their potential for use in tissue repair and molecular medicine. J Cell Mol Med. 2005; 9(3):753-69. PMC: 6741352. DOI: 10.1111/j.1582-4934.2005.tb00510.x. View

16.

Tateishi K, Takehara N, Matsubara H, Oh H . Stemming heart failure with cardiac- or reprogrammed-stem cells. J Cell Mol Med. 2008; 12(6A):2217-32. PMC: 4514101. DOI: 10.1111/j.1582-4934.2008.00487.x. View

17.

Kamihata H, Matsubara H, Nishiue T, Fujiyama S, Tsutsumi Y, Ozono R . Implantation of bone marrow mononuclear cells into ischemic myocardium enhances collateral perfusion and regional function via side supply of angioblasts, angiogenic ligands, and cytokines. Circulation. 2001; 104(9):1046-52. DOI: 10.1161/hc3501.093817. View

18.

Zimmet H, Krum H . Using adult stem cells to treat heart failure--fact or fiction?. Heart Lung Circ. 2008; 17 Suppl 4:S48-54. DOI: 10.1016/j.hlc.2008.09.006. View

19.

Spinetti G, Kraenkel N, Emanueli C, Madeddu P . Diabetes and vessel wall remodelling: from mechanistic insights to regenerative therapies. Cardiovasc Res. 2008; 78(2):265-73. PMC: 2821012. DOI: 10.1093/cvr/cvn039. View

20.

Park I, Zhao R, West J, Yabuuchi A, Huo H, Ince T . Reprogramming of human somatic cells to pluripotency with defined factors. Nature. 2007; 451(7175):141-6. DOI: 10.1038/nature06534. View